Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
NEPHRO-AVERRO from Ittre, company number BE0806299830, closed financial year 2025 with a result of € -30,302 after tax. For that financial year NEPHRO-AVERRO recorded a gross margin of € 2,242 and equity of € 83,949. Compared with financial year 2024, the result moved from € 64,187 to € -30,302. The company made a loss. The buffer shrank hard: equity is 53 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ 83,949
▼ 53% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -30,302
▼ still € 64,187 profit in 2024
Profit after tax over the fiscal year.
€ 16,449
▼ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 82,949.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 46,045
▼ 38% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 47,792
▼ 29% vs 2024
€ 29,178 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 6,331
▼ 58% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,903
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 44,333 | € 57,298 | € 122,583 | € 2,242 | ▼ 98% |
| Profit after taxes | € 23,446 | € 16,399 | € 64,187 | € -30,302 | ▼ € 94,490 |
| Equity | € 141,976 | € 113,656 | € 177,844 | € 83,949 | ▼ 53% |
| Total debts | € 177,410 | € 182,355 | € 103,402 | € 144,292 | ▲ 40% |
| Cash | € 5,421 | € 40,964 | € 25,451 | € 16,449 | ▼ 35% |
| Retained profit | € 129,290 | € 112,656 | € 176,844 | € 82,949 | ▼ 53% |
| Dividend | € 75,755 | € 44,719 | € 0 | € 63,592 | |
| Bank debt | € 116,895 | € 92,387 | € 67,588 | € 47,792 | ▼ 29% |
| Balance sheet total | € 319,385 | € 296,011 | € 281,245 | € 228,241 | ▼ 19% |
Key figures of NEPHRO-AVERRO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NEPHRO-AVERRO?
What happened at NEPHRO-AVERRO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 30,302 (▼ € 94,490 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 23,446 profit in 2022 to € 30,302 loss in 2025.
Paid € 38,011 in corporate taxes since 2022.
Best year ever: 2024, with € 64,187 profit.
Paid out € 184,066 in dividends to the owners in total.
A new publication or filing at NEPHRO-AVERRO? We notify you, reason included.
Follow NEPHRO-AVERRODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind NEPHRO-AVERRO is PHILIPPE MADHOUN.
Directors
According to the 2025 annual accounts
PHILIPPE MADHOUN
Director
Establishments
Establishment units
Physical locations of this company
Rue Cardinal Mercier 39
1460 Ittre
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0806.299.830
- VAT number
- BE 0806.299.830
- Registered office
- Rue Cardinal Mercier 39, 1460 Ittre
- Names & denominations
- NEPHRO-AVERRO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 September 2008
- Peppol
- Active · Active since 6 Dec 2025
- Contact
- [email protected]